Table 3.
3 months | |||||
---|---|---|---|---|---|
ΔDAS28 | ΔDAS28-CRP | ΔSDAI | ΔCDAI | ||
ΔSUV (12 joints) | r | 0.615* | 0.696* | 0.652* | 0.662* |
p | 0.009 | 0.002 | 0.005 | 0.004 | |
ΔSUV (8 joints) | r | 0.61* | 0.723* | 0.637* | 0.64* |
p | 0.009 | 0.001 | 0.006 | 0.006 | |
6 months | |||||
ΔDAS28 | ΔDAS28-CRP | ΔSDAI | ΔCDAI | ||
ΔSUV (12 joints) | r | 0.775* | 0.828* | 0.686* | 0.711* |
p | <0.001 | <0.001 | 0.002 | 0.001 | |
ΔSUV (8 joints) | r | 0.749* | 0.775* | 0.623* | 0.686* |
p | 0.001 | <0.001 | 0.008 | 0.002 |
The ΔSUV (12/8 joints), the difference in the total SUVmax of the affected 12 or eight (bilateral shoulder, elbow, wrist and knee) joints before and after treatment, was significantly correlated with the ΔDAS28, ΔDAS28-CRP, ΔSDAI and ΔCDAI. *indicates a significant correlation following the Bonferroni correction.